EUVIMEDEUVIMED entdecken
Multizentrische Studie

Outcome of immunosuppression in children with IgA vasculitis–related nephritis

Katharina Rohner iD, Matko Marlais, Yo Han Ahn, Alaa Ali, Abrar Alsharief, Anja Blejc Novak, Marta Brambilla, Evrim Kargin Cakici, Cengiz Candan, Nur Canpolat, Eugene Yu-Hin Chan, Stéphane Decramer und 39 weitere

Nephrology Dialysis Transplantation · 31.07.2024 · 39 (8) · 1299-1309

DOI: 10.1093/ndt/gfae009 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 11.01.2024. Verfasst von Katharina Rohner und 50 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nephrology, University Children's Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Glomerular Filtration Rate, Immunosuppressive Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunoglobulin A vasculitis with nephritis (IgAVN) is the most common vasculitis in children. Due to a lack of evidence, treatment recommendations are based on expert opinion, resulting in variation. The aim of this study was to describe the clinical presentation, treatment and outcome of an extremely large cohort of children with biopsy-proven IgAVN in order to identify prognostic risk factors and signals of treatment efficacy.

Methods

Retrospective data were collected on 1148 children with biopsy-proven IgAVN between 2005 and 2019 from 41 international paediatric nephrology centres across 25 countries and analysed using multivariate analysis. The primary outcome was estimated glomerular filtration rate (eGFR) and persistent proteinuria at last follow-up.

Results

The median follow-up was 3.7 years (interquartile range 2–6.2). At last follow-up, 29% of patients had an eGFR <90 mL/min/1.73 m2, 36% had proteinuria and 3% had chronic kidney disease stage 4–5. Older age, lower eGFR at onset, hypertension and histological features of tubular atrophy and segmental sclerosis were predictors of poor outcome. There was no evidence to support any specific second-line immunosuppressive regimen being superior to others, even when further analysing subgroups of children with reduced kidney function, nephrotic syndrome or hypoalbuminemia at onset. Delayed start of immunosuppressive treatment was associated with a lower eGFR at last follow-up.

Conclusion

In this large retrospective cohort, key features associated with disease outcome are highlighted. Importantly, there was no evidence to support that any specific immunosuppressive treatments were superior to others. Further discovery science and well-conducted clinical trials are needed to define accurate treatment and improve outcomes of IgAVN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glomerular Filtration RateImmunosuppressive AgentsHumansMaleChildFemaleRetrospective StudiesAdolescentChild, PreschoolPrognosisGlomerulonephritis, IGAFollow-Up StudiesImmunosuppression TherapyIgA VasculitisTreatment OutcomeVasculitis

Stichwörter der Autor:innen

Henoch-Schönlein purpura nephritisIgA vasculitis nephritischildrenimmunosuppression

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pediatric Nephrology, University Children's Hospital Zurich, Zurich, Switzerland.
  • Paediatric Nephrology Department, Great Ormond Street Hospital for Children, London, UK.
  • UCL Great Ormond Street Institute for Child Health, University College London, London, UK.
  • Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Great North Children's Hospital Newcastle, Newcastle, UK.
  • Department of Pediatric Nephrology, The Queen Silvia Children´s Hospital, Sahlgrenska University Hospital, Göteborg, Sweden.

ORCID-Profile: Katharina Rohner, Anne M Durkan, Ali Düzova, Valentina Gracchi, Eda Didem Kurt-Sukur, Antonio Mastrangelo, Takayuki Okamoto, Louise Oni, Pornpimol Rianthavorn, Rezan Topaloglu

Zitieren

APA

Rohner, K., Marlais, M., Ahn, Y. H., Ali, A., Alsharief, A., Novak, A. B., Brambilla, M., Cakici, E. K., Candan, C., Canpolat, N., Chan, E. Y., Decramer, S., Didsbury, M., Durao, F., Durkan, A. M., Düzova, A., Forbes, T., Gracchi, V., Güngör, T., …, & Tullus, K. (2024). Outcome of immunosuppression in children with IgA vasculitis–related nephritis. Nephrology Dialysis Transplantation, 39(8), 1299-1309. https://doi.org/10.1093/ndt/gfae009

Vancouver

Rohner K, Marlais M, Ahn YH, Ali A, Alsharief A, Novak AB, et al. Outcome of immunosuppression in children with IgA vasculitis–related nephritis. Nephrology Dialysis Transplantation. 2024;39(8):1299-1309. doi:10.1093/ndt/gfae009

BibTeX
@article{Rohner2024,
  author = {Rohner, Katharina and Marlais, Matko and Ahn, Yo Han and Ali, Alaa and Alsharief, Abrar and Novak, Anja Blejc and Brambilla, Marta and Cakici, Evrim Kargin and Candan, Cengiz and Canpolat, Nur and Chan, Eugene Yu-Hin and Decramer, Stéphane and Didsbury, Madeleine and Durao, Filipa and Durkan, Anne M and Düzova, Ali and Forbes, Thomas and Gracchi, Valentina and Güngör, Tulin and Horinouchi, Tomoko and Kasap Demir, Belde and Kobayashi, Yasuko and Koskela, Mikael and Kurt-Sukur, Eda Didem and La Scola, Claudio and Langan, Dean and Li, Xiaozhong and Malgieri, Gabriele and Mastrangelo, Antonio and Min, Jeesu and Mizerska-Wasiak, Malgorzata and Moussaoui, Nabila and Noyan, Aytul and Nuutinen, Matti and O'Gormon, Jennifer and Okamoto, Takayuki and Oni, Louise and Oosterveld, Michiel and Pańczyk-Tomaszewska, Malgorzata and Parmaksiz, Gonul and Pasini, Andrea and Rianthavorn, Pornpimol and Roelofs, Joris and Shen, Yunyan and Sinha, Rajiv and Topaloglu, Rezan and Torres, Diletta Domenica and Udagawa, Tomohiro and Wennerström, Martin and Yap, Yok Chin and Tullus, Kjell},
  title = {Outcome of immunosuppression in children with IgA vasculitis–related nephritis},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  volume = {39},
  number = {8},
  pages = {1299--1309},
  doi = {10.1093/ndt/gfae009}
}
Kostenlos starten →